ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,974Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 307

$837K Total Retail Price of All Prescriptions

Rank: 5 out of 307

572 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 572 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 572 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 17,448 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 1,077 1,018 1 2
LEVOTHYROXINE SODIUM 838 825 2 1
OMEPRAZOLE 824 763 3 5
POTASSIUM CHLORIDE 689 670 4 10
FUROSEMIDE 546 541 5 6
WARFARIN SODIUM 468 468 6 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 442 421 7 23
METOPROLOL SUCCINATE 423 401 8 13
NABUMETONE 416 391 9 102
AMLODIPINE BESYLATE 416 403 9 7
LISINOPRIL 410 399 11 3
ALENDRONATE SODIUM 407 390 12 20
CARVEDILOL 366 365 13 24
TAMSULOSIN HCL 303 278 14 21
PREDNISONE 297 258 15 37
LOSARTAN-HYDROCHLOROTHIAZIDE 259 240 16 46
METOPROLOL TARTRATE 257 227 17 12
LOSARTAN POTASSIUM 249 249 18 16
PRAVASTATIN SODIUM 229 221 19 26
FLUTICASONE PROPIONATE 203 180 20 44
ADVAIR DISKUS 201 189 21 28
METFORMIN HCL 197 177 22 8
TRIAMTERENE-HCTZ 196 187 23 42
FINASTERIDE 194 182 24 105
HYDROCHLOROTHIAZIDE 189 185 25 9
OXYCODONE-ACETAMINOPHEN 172 164 S2 26 63
CITALOPRAM HBR 172 171 26 14
GABAPENTIN 170 138 28 15
ENALAPRIL MALEATE 168 159 29 54
ATORVASTATIN CALCIUM 158 157 30 18
SPIRONOLACTONE 142 127 31 40
ALLOPURINOL 141 125 32 27
PAROXETINE HCL 137 109 33 43
DOXYCYCLINE HYCLATE 135 118 34 133
DIGOXIN 135 123 34 36
TORSEMIDE 133 133 36 111
AZITHROMYCIN 130 113 37 55
HYDROCODONE-ACETAMINOPHEN 126 115 S3 38 4
ZOLPIDEM TARTRATE 123 111 39 19
RISPERIDONE 122 85 40 62
FENTANYL 113 101 S2 41 35
GLIMEPIRIDE 112 105 42 60
AMIODARONE HCL 110 104 43 135
SERTRALINE HCL 105 90 44 22
METFORMIN HCL ER 104 103 45 52
CELEBREX 102 102 46 147
ROPINIROLE HCL 100 97 47 74
ACTOS 94 85 48 93
CLOPIDOGREL 93 88 49 59
ALBUTEROL SULFATE 91 90 50 118
ATENOLOL 88 73 51 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 80 52 84
AMITRIPTYLINE HCL 83 83 R 52 65
ISOSORBIDE MONONITRATE ER 81 80 54 78
CRESTOR 79 73 55 39
IPRATROPIUM BROMIDE 77 77 56 168
TRAMADOL HCL 74 61 57 25
DONEPEZIL HCL 74 74 57 34
CIPROFLOXACIN HCL 74 69 57 83
PANTOPRAZOLE SODIUM 73 73 60 49
ZETIA 72 72 61 119
ZOSTAVAX 72 69 61 81
VENTOLIN HFA 70 66 63 98
SPIRONOLACTONE-HCTZ 70 58 63 146
CYMBALTA 66 49 65 30
SPIRIVA 64 64 66 48
DILT-XR 63 63 67 201
CILOSTAZOL 62 55 68 202
BACLOFEN 60 48 69 79
POLYETHYLENE GLYCOL 3350 59 48 70 50
LUNESTA 58 58 71 213
LANTUS 57 57 72 47
TRIAMCINOLONE ACETONIDE 57 56 72 129
SOTALOL 56 56 74 184
PROAIR HFA 56 34 74 53
FLOVENT HFA 56 56 74 218
MUPIROCIN 56 53 74 218
FLUOXETINE HCL 55 37 78 32
CYCLOBENZAPRINE HCL 55 45 R 78 75
ACETAMINOPHEN-CODEINE 54 54 S3 80 86
PRIMIDONE 54 41 80 225
JANUVIA 53 47 82 97
CARBIDOPA-LEVODOPA 52 48 83 94
TRAZODONE HCL 51 30 84 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.